MYBPHL
Myosin-binding protein H-like
Also known as: MBPHL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A2RUH7
- Gene
- MYBPHL
- Ensembl
- ENSG00000221986
- Chromosome
- 1
- Canonical length
- 354 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a protein with two immunoglobulin superfamily domains and a fibronectin 3 domain. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
Canonical amino-acid sequenceUniProt
354 residues, UniProt reviewed canonical sequence.
>A2RUH7|MYBPHL
1 MEAATAPEVA AGSKLKVKEA SPADAEPPQA SPGQGAGSPT PQLLPPIEEH PKIWLPRALR
61 QTYIRKVGDT VNLLIPFQGK PKPQAIWTHD GCALDTRRVS VRNGEQDSIL FIREAQRADS
121 GRYQLRVQLG GLEATATIDI LVIERPGPPQ SIKLVDVWGF SATLEWTPPQ DTGNTALLGY
181 TVQKADTKSG LWFTVLEHYH RTSCIVSDLI IGNSYAFRVF AENQCGLSET APITTDLAHI
241 QKAATVYKTK GFAQRDFSEA PKFTQPLADC TTVTGYNTQL FCCVRASPRP KIIWLKNKMD
301 IQGNPKYRAL THLGICSLEI RKPGPFDGGI YTCKAVNPLG EASVDCRVDV KVPNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYBPHL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 101 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 101 nTPM
- pituitary gland: 2.8 nTPM
- fallopian tube: 2.2 nTPM
- retina: 1.9 nTPM
- lung: 1.1 nTPM
- hippocampal formation: 1 nTPM
Single-cell type
- rod photoreceptor cells: 18 nCPM
- myosatellite cells: 9 nCPM
- corticotrophs: 6.8 nCPM
- mesothelial cells: 5.5 nCPM
- podocytes: 4.6 nCPM
- alveolar cells type 2: 4.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 6.2 nTPM
- white matter: 5.5 nTPM
- hippocampal formation: 5.1 nTPM
- basal ganglia: 3.1 nTPM
- medulla oblongata: 2 nTPM
- midbrain: 2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
- sarcomere
- myofilament
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Striated Muscle Structural and Regulatory Protein
- Fibronectin type III domain
- Immunoglobulin I-set domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYBPHL as an antibody target. Whether an autoantibody or antibody against MYBPHL could matter depends on whether native MYBPHL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYBPHL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYBPHL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...